International HIV Antiretroviral Adherence, Resistance and Survival (UARTO)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Massachusetts General Hospital
Sponsor:
Collaborators:
University of California, San Francisco
Mbarara University of Science and Technology
University of British Columbia
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
David Bangsberg, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01596322
First received: April 22, 2010
Last updated: April 6, 2015
Last verified: April 2015